Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Roh

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 25, 2007
Combined 18F-fluorodeoxyglucose-positron emission tomography and computed tomography as a primary screening method for detecting second primary cancers and distant metastases in patients with head and neck cancerS Y Kim, J-L Roh, N-K Yeo, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|December 14, 2016
Incidence and risk factors of late recurrence in patients with salivary gland cancerG C Park, J-L Roh, K-J Cho, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 10, 2012
Risk factors for non-cancer health events in patients with head and neck squamous cell carcinomaC H Ryu, J-L Roh, S-B Kim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 2014
Noncancer health events as a leading cause of competing mortality in advanced head and neck cancerM Kwon, J-L Roh, J Song, et al.
The British Journal of Surgery|December 21, 2012
Preoperative detection and predictors of level V lymph node metastasis in patients with papillary thyroid carcinomaM J Shim, J-L Roh, G Gong, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 20, 2007
2-[18F]-Fluoro-2-deoxy-D-glucose positron emission tomography as guidance for primary treatment in patients with advanced-stage resectable squamous cell carcinoma of the larynx and hypopharynxJ-L Roh, K H Pae, S-H Choi, et al.
Clinical Radiology|August 30, 2016
Interobserver reproducibility of cervical lymph node measurements at CT in patients with head and neck squamous cell carcinomaM S Chung, K L Cheng, Y J Choi, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 30, 2007
Utility of 18F-fluorodeoxyglucose positron emission tomography in the preoperative staging of squamous cell carcinoma of the oropharynxM R Kim, J-L Roh, J S Kim, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 8, 2007
Utility of FDG PET in patients with squamous cell carcinomas of the oral cavityS Y Kim, J-L Roh, J S Kim, et al.
British Journal of Cancer|October 24, 2013
(18)F-FDG PET/CT surveillance at 3-6 and 12 months for detection of recurrence and second primary cancer in patients with head and neck squamous cell carcinomaJ W Kim, J-L Roh, J S Kim, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 25, 2007
Combined 18F-fluorodeoxyglucose-positron emission tomography and computed tomography as a primary screening method for detecting second primary cancers and distant metastases in patients with head and neck cancerS Y Kim, J-L Roh, N-K Yeo, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|December 14, 2016
Incidence and risk factors of late recurrence in patients with salivary gland cancerG C Park, J-L Roh, K-J Cho, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 10, 2012
Risk factors for non-cancer health events in patients with head and neck squamous cell carcinomaC H Ryu, J-L Roh, S-B Kim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 2014
Noncancer health events as a leading cause of competing mortality in advanced head and neck cancerM Kwon, J-L Roh, J Song, et al.
The British Journal of Surgery|December 21, 2012
Preoperative detection and predictors of level V lymph node metastasis in patients with papillary thyroid carcinomaM J Shim, J-L Roh, G Gong, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 20, 2007
2-[18F]-Fluoro-2-deoxy-D-glucose positron emission tomography as guidance for primary treatment in patients with advanced-stage resectable squamous cell carcinoma of the larynx and hypopharynxJ-L Roh, K H Pae, S-H Choi, et al.
Clinical Radiology|August 30, 2016
Interobserver reproducibility of cervical lymph node measurements at CT in patients with head and neck squamous cell carcinomaM S Chung, K L Cheng, Y J Choi, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 30, 2007
Utility of 18F-fluorodeoxyglucose positron emission tomography in the preoperative staging of squamous cell carcinoma of the oropharynxM R Kim, J-L Roh, J S Kim, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 8, 2007
Utility of FDG PET in patients with squamous cell carcinomas of the oral cavityS Y Kim, J-L Roh, J S Kim, et al.
British Journal of Cancer|October 24, 2013
(18)F-FDG PET/CT surveillance at 3-6 and 12 months for detection of recurrence and second primary cancer in patients with head and neck squamous cell carcinomaJ W Kim, J-L Roh, J S Kim, et al.
Pageof 3